Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.22
-0.01 (-0.03%)
At close: Mar 9, 2026, 4:00 PM EDT
38.20
-0.02 (-0.05%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Crinetics Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -465.32 | -298.41 | -214.53 | -163.92 | -107.64 | |
| Depreciation & Amortization | 3.89 | 2.79 | 1.1 | 0.98 | 0.92 | |
| Loss (Gain) From Sale of Assets | 0.05 | 0.05 | 0.01 | - | - | |
| Loss (Gain) From Sale of Investments | -15.43 | -14.93 | -6.27 | 0.03 | 0.42 | |
| Loss (Gain) on Equity Investments | - | 0.47 | 5.2 | 1.01 | - | |
| Stock-Based Compensation | 91.02 | 69.39 | 40.94 | 28.27 | 17.35 | |
| Other Operating Activities | 3.01 | 3.04 | -0.79 | -0.19 | -0.74 | |
| Change in Accounts Receivable | -0.59 | - | - | - | - | |
| Change in Inventory | -2.02 | - | - | - | - | |
| Change in Accounts Payable | 28.98 | 13.32 | 12.36 | 10.99 | 6.29 | |
| Change in Unearned Revenue | -1.84 | 0.07 | -1.54 | 8.34 | - | |
| Change in Other Net Operating Assets | -19.69 | -5.98 | -5.07 | -0.72 | -5.2 | |
| Operating Cash Flow | -377.92 | -230.19 | -168.6 | -115.21 | -88.59 | |
| Capital Expenditures | -5.76 | -3.84 | -4.69 | -1.66 | -0.44 | |
| Investment in Securities | 179.67 | -570.97 | -195.73 | -172.32 | -56.05 | |
| Investing Cash Flow | 173.91 | -574.82 | -200.41 | -173.98 | -56.48 | |
| Issuance of Common Stock | 40.61 | 1,030 | 391.78 | 129.72 | 265.64 | |
| Other Financing Activities | - | -14.98 | -0.54 | -7.76 | -12.96 | |
| Financing Cash Flow | 40.61 | 1,015 | 391.24 | 121.96 | 252.68 | |
| Foreign Exchange Rate Adjustments | -0.11 | - | - | - | - | |
| Net Cash Flow | -163.51 | 209.65 | 22.22 | -167.22 | 107.61 | |
| Free Cash Flow | -383.68 | -234.04 | -173.29 | -116.86 | -89.02 | |
| Free Cash Flow Margin | -4985.50% | -22525.31% | -4318.12% | -2466.98% | -8258.26% | |
| Free Cash Flow Per Share | -4.08 | -2.90 | -2.98 | -2.25 | -2.32 | |
| Levered Free Cash Flow | -206.91 | -136.41 | -93.53 | -62.51 | -48.47 | |
| Unlevered Free Cash Flow | -206.91 | -136.41 | -93.53 | -62.51 | -48.47 | |
| Change in Working Capital | 4.84 | 7.41 | 5.75 | 18.61 | 1.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.